Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

FDA approves Sevenfact for hemophilia A and B

April 2, 2020

FORMA Therapeutics identifies new pyruvate kinase PKLR activators

April 2, 2020

FDA accepts IND application for OTQ-923

April 2, 2020

FDA approves new intravenous formulation of Triferic

March 30, 2020

Otsuka Pharmaceutical identifies AhR antagonists

March 25, 2020

Desmopressin shows promise for the management of bleeding in rectal cancer

March 20, 2020

Cellphire cleared to begin phase II study of Thrombosomes in bleeding patients with thrombocytopenia

March 19, 2020

Novo Nordisk announces decision to pause concizumab trials in hemophilia

March 17, 2020

Keeping stem cells quiescent enables greater ultimate potency

March 10, 2020

BioCryst initiates proof-of-concept trial of BCX-9930 in PNH

March 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...